KR20030080623A - 금연을 돕는 조성물 및 제조방법 - Google Patents
금연을 돕는 조성물 및 제조방법 Download PDFInfo
- Publication number
- KR20030080623A KR20030080623A KR1020020019345A KR20020019345A KR20030080623A KR 20030080623 A KR20030080623 A KR 20030080623A KR 1020020019345 A KR1020020019345 A KR 1020020019345A KR 20020019345 A KR20020019345 A KR 20020019345A KR 20030080623 A KR20030080623 A KR 20030080623A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- smoking
- smoking cessation
- nicotine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 230000000391 smoking effect Effects 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title abstract description 7
- 239000000284 extract Substances 0.000 claims abstract description 23
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 8
- 230000005586 smoking cessation Effects 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 235000020723 lavender extract Nutrition 0.000 claims description 5
- 229940083980 lavender extract Drugs 0.000 claims description 5
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 3
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 235000020710 ginseng extract Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000017807 phytochemicals Nutrition 0.000 claims 1
- 229930000223 plant secondary metabolite Natural products 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract description 7
- 244000178870 Lavandula angustifolia Species 0.000 abstract description 7
- 235000010663 Lavandula angustifolia Nutrition 0.000 abstract description 7
- 239000001102 lavandula vera Substances 0.000 abstract description 7
- 235000018219 lavender Nutrition 0.000 abstract description 7
- 241000269837 Artemisia dubia Species 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000002020 sage Nutrition 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 15
- 229960002715 nicotine Drugs 0.000 description 15
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 10
- 241000208125 Nicotiana Species 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 235000019504 cigarettes Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000002670 nicotine replacement therapy Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000009429 Ginkgo biloba extract Substances 0.000 description 4
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 description 4
- 229960001058 bupropion Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000000779 smoke Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010062038 Lip neoplasm Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002738 anti-smoking effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008309 brain mechanism Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 201000006721 lip cancer Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940015769 nicotine chewing gum Drugs 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940124535 smoking cessation aid Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
- 왕질경이 추출물, 서향 추출물, 은행잎 추출물과 라벤더 추출물을 유효 성분으로 하는 금연 휘산제 조성물.
- 제 1 항에 있어서, 상기 조성물에 솔잎 추출물 및 인삼 추출물로 이루어진 군으로부터 1 종 이상선택되는 추출물을 더욱 포함하는 금연 휘산제 조성물.
- 제 1 항 및 제 2 항의 어느 한 항에 있어서, 상기 왕질경이 추출물의 조성물 내 함유량이 0.1 내지 10 중량%인 금연 휘산제 조성물.
- 제 1 항 및 제 2 항의 어느 한 항에 있어서, 상기 서향 추출물의 조성물 내 함유량이 0.1 내지 10 중량%인 금연 휘산제 조성물.
- 제 1 항 내지 제 2 항의 어느 한 항에 있어서, 상기 추출물들은 100 중량부를 에탄올 농도 30 내지 100 중량%의 에탄올 수용액 500 내지 1000 중량부로 추출하여 제조되는 금연 휘산제 조성물.
- 제 1 항 내지 제 2 항의 어느 한 항에 있어서, 상기 금연 조성물의 제형이 휘산 또는 스프레이인 금연 조성물.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020019345A KR20030080623A (ko) | 2002-04-09 | 2002-04-09 | 금연을 돕는 조성물 및 제조방법 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020019345A KR20030080623A (ko) | 2002-04-09 | 2002-04-09 | 금연을 돕는 조성물 및 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20030080623A true KR20030080623A (ko) | 2003-10-17 |
Family
ID=32378360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020020019345A Ceased KR20030080623A (ko) | 2002-04-09 | 2002-04-09 | 금연을 돕는 조성물 및 제조방법 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20030080623A (ko) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR880013554A (ko) * | 1987-05-01 | 1988-12-21 | 원본미기재 | 금연 관련 금단증상의 치료법 및 그치료법에 사용되는 제제 |
| JPH11137232A (ja) * | 1997-08-02 | 1999-05-25 | Ever Bright Ind Corp | ハーブ製品 |
| WO1999027943A1 (fr) * | 1997-12-03 | 1999-06-10 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Utilisation d'extraits de ginkgo biloba pour preparer un medicament |
| KR20010014750A (ko) * | 1999-07-16 | 2001-02-26 | 정종문 | 니코틴 분해음료 및 제재 |
| KR200231153Y1 (ko) * | 2001-01-26 | 2001-07-03 | 김진경 | 금단현상 치료 보조용 건조 인삼 권련 |
| KR200251152Y1 (ko) * | 2001-07-11 | 2001-11-17 | 김진경 | 향신료와 니코틴과 카페인을 첨가한 금단현상 치료보조용 건조 은행잎 권련 |
| KR20030010166A (ko) * | 2001-07-25 | 2003-02-05 | 조주환 | 은행잎 성분을 이용한 권련용 여재 및 그 제조방법 |
-
2002
- 2002-04-09 KR KR1020020019345A patent/KR20030080623A/ko not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR880013554A (ko) * | 1987-05-01 | 1988-12-21 | 원본미기재 | 금연 관련 금단증상의 치료법 및 그치료법에 사용되는 제제 |
| JPH11137232A (ja) * | 1997-08-02 | 1999-05-25 | Ever Bright Ind Corp | ハーブ製品 |
| WO1999027943A1 (fr) * | 1997-12-03 | 1999-06-10 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Utilisation d'extraits de ginkgo biloba pour preparer un medicament |
| KR20010014750A (ko) * | 1999-07-16 | 2001-02-26 | 정종문 | 니코틴 분해음료 및 제재 |
| KR200231153Y1 (ko) * | 2001-01-26 | 2001-07-03 | 김진경 | 금단현상 치료 보조용 건조 인삼 권련 |
| KR200251152Y1 (ko) * | 2001-07-11 | 2001-11-17 | 김진경 | 향신료와 니코틴과 카페인을 첨가한 금단현상 치료보조용 건조 은행잎 권련 |
| KR20030010166A (ko) * | 2001-07-25 | 2003-02-05 | 조주환 | 은행잎 성분을 이용한 권련용 여재 및 그 제조방법 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100506241C (zh) | 一种戒烟保健吸品及其制作方法 | |
| Grieve | A modern herbal, vol. II | |
| KR100739872B1 (ko) | 녹차를 주성분으로 한 담배대용품 및 그 제조방법 | |
| Bakhru | Herbs that heal: natural remedies for good health | |
| US20050241658A1 (en) | Composition to reduce or quit smoking addiction | |
| JP7303969B2 (ja) | 電子タバコ用液体組成物及びそれを有する電子タバコ | |
| CN1408291A (zh) | 无尼古丁香烟及低尼古丁香烟 | |
| WO2017155515A1 (en) | Herbal sonicated e-nano e-liquid mix for zero-nicotine e-cigarette for improving smoker's health | |
| Christison | On the natural history, action, and uses of Indian hemp | |
| CN109645549A (zh) | 一种戒烟用的香烟 | |
| US6776169B1 (en) | Ginkgo biloba L. leaves cigarette | |
| KR19990000236A (ko) | 금연겸용 끽연물 및 이의 제조방법 | |
| CN111642786A (zh) | 一种具有防疫和保健功效的中草药茶烟及其应用 | |
| JP2959712B2 (ja) | 禁煙兼用喫煙物及びその製造方法 | |
| KR100470957B1 (ko) | 담배의 제조방법 | |
| Grover | Man and plants against pain | |
| US20070042054A1 (en) | Functional aphrodisiac rolled herbal bidis and cigarettes | |
| Vaishnavi et al. | A review on anesthetic herbs | |
| KR20030080623A (ko) | 금연을 돕는 조성물 및 제조방법 | |
| KR20030050729A (ko) | 천연식물을 추가한 끽연물의 제조방법 | |
| KR100851254B1 (ko) | 뽕잎을 주성분으로 한 담배 및 그 제조방법 | |
| WO2020094610A1 (en) | New tobacco substitutes | |
| KR100370390B1 (ko) | 토근의 알칼로이드를 포함하는 금연 유도 조성물 | |
| Manolova | Natural pharmacy | |
| US8399031B1 (en) | Compositions and methods for restoring pulmonary function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20020409 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040831 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20041125 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040916 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20040831 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20041210 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040916 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20040831 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |